Procurement Summary
Country: USA
Summary: Dow Lupus, Idea Award
Deadline: 24 Aug 2026
Posting Date: 06 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140728286
Document Ref. No.: HT942526LRPIA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Summary: This Funding Mechanism Supports Innovative, High-Risk/High-Reward Research That Could Ultimately Lead To A Critical Discovery Or Major Advancement Relevant To Lupus. The Emphasis Is On Innovation. Research Must Address At Least One Of The Fiscal Year 2026 (Fy26) Lupus Research Program (Lrp) Idea Award (Ia) Focus Areas. This Funding Mechanism Does Not Allow Clinical Trials.Distinctive Features:• Early-Career Investigators Are Eligible To Serve As Principal Investigators (Pis) On Applications To The Fy26 Lrp Idea Award (See Section 2. Eligibility Information).• Preliminary Data Are Permitted But Not Required.• Applications Should Describe Future Directions Of The Work.• An Individual May Be Named As Pi On Only One Application Per Lrp Award Mechanism (Ia, Impact Award, Transformative Vision Development Award, Transformative Vision Award), For A Maximum Of Four Applications To The Fy26 Lrpeligibilityeligible Applicantsmiscellaneousunrestrictedadditional Informationgrantor Contact Informationdescriptionebrap Help Desk Phone: 301-682-5507 Email: [email protected] Help Deskdocumentsfile Namedescriptionlast Updatedfy26 Lrp Ia Program Announcementmay 5, 2026 02:19 Pm Utclink To Additional Information--Closing: August 24, 2026
Posted Date: 2026-05-05 00:00:00
Funding instrument type: Grant
Documents
Tender Notice